Artemis Pharma Inc.
Artemis Pharma Inc. is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Artemis Pharma Inc..
Artemis Pharma Inc. is a company.
Key people at Artemis Pharma Inc..
Artemis Pharma Inc. appears to refer to multiple entities with similar names, but based on available information, the most relevant and active entity is Artemis Life Sciences (Nig) Ltd, a pharmaceutical manufacturing company operating primarily in Nigeria and part of the Vista Group headquartered in Dubai. Artemis Life Sciences focuses on pharmaceutical formulations and medical equipment, serving healthcare markets with a broad network across Africa and beyond[1][3].
Artemis Life Sciences builds pharmaceutical products and medical equipment, serving healthcare providers and patients primarily in Nigeria and other African countries. The company addresses the critical need for accessible, quality pharmaceutical formulations and medical supplies in emerging markets. It operates within the pharmaceutical manufacturing sector, contributing to healthcare infrastructure and improving access to essential medicines. The company has demonstrated steady growth with a workforce of around 30 employees and revenues in the multimillion-dollar range, supported by Vista Group’s extensive network and market knowledge[1][3].
Founded in 2017, Artemis Life Sciences is a subsidiary of the Vista Group, which has a 30-year history and presence in 15 countries across Africa and globally. The founding of Artemis Life Sciences aligns with Vista Group’s strategic expansion into pharmaceutical manufacturing to leverage its market expertise and professional network. The company’s origin is rooted in addressing pharmaceutical supply challenges in Nigeria and the broader African continent, capitalizing on Vista Group’s established alliances and market insights[1][3].
Artemis Life Sciences rides the trend of increasing demand for localized pharmaceutical manufacturing in emerging markets, driven by global supply chain disruptions and the need for healthcare self-sufficiency. The timing is critical as African countries seek to reduce dependency on imports for essential medicines. Market forces such as growing populations, rising healthcare awareness, and government initiatives to boost local pharmaceutical production favor Artemis’s growth. The company influences the ecosystem by enhancing pharmaceutical availability and supporting healthcare infrastructure development in Nigeria and neighboring regions[1][3].
Looking ahead, Artemis Life Sciences is positioned to expand its footprint in Africa’s pharmaceutical sector, leveraging Vista Group’s network and expertise. Trends such as digital transformation in healthcare, increased regulatory support for local manufacturing, and rising demand for affordable medicines will shape its trajectory. The company’s influence may grow as it contributes to healthcare resilience and innovation in pharmaceutical supply chains across emerging markets.
---
Note: There is also a mention of an entity named Artemis Therapeutics, Inc., incorporated in Delaware in 2016, which was engaged in developing treatments for infectious diseases but ceased operations and is now classified as a shell company since 2019[2]. This entity appears unrelated to Artemis Life Sciences (Nig) Ltd.
Additionally, Artemis Health is a separate company focused on healthcare benefits data analytics and is unrelated to Artemis Pharma Inc.[4].
Key people at Artemis Pharma Inc..